Wade’s Health Law Highlights for November 17, 2026
Read the issue: Wade’s Health Law Highlights for November 17, 2026OIG approved a drug manufacturer’s plan to pay for autoantibody testing that helps determine whether its drug for a rare lung disease may be appropriate for a patient. Under Advisory Opinion 26-20, the manufacturer would pay a third-party laboratory a fixed fee…
Recent Health Law Highlights Issues
Texas Medical Center Wrestles With Promise, Perils of AI
Summary of article from Houston Chronicle, by Jim Magill: The Texas Medical Center is increasingly integrating AI into healthcare, recognizing both its…
Post-Chevron Health Care Regulations: The Dawn of a New Day
Summary of article from ArentFox Schiff, by Douglas a. Grimm, Lowell C. Brown, David S. Greenberg, Pascal Naples: The Supreme Court’s decision…
An Introduction to Healthcare AI Innovation in an Evolving Regulatory Landscape
Summary of article from Benesch, by Arielle Lester, Vince Nardone, Amanda Ray, Kathrin Zaki: The expansion of AI applications in healthcare is…
The Limits of AI in Healthcare: Exploring Ethical and Practical Challenges
Summary of article from Nelson Hardiman, LLP, by Harry Nelson: The integration of AI in healthcare, exemplified by companies like RealtimeMed and…
False Claims Act Settlements to Know from Q2 2024
Summary of article from Bass, Berry & Sims PLC, by Latazia Carter, Scott Gallisdorfer: In Q2 2024, the Department of Justice announced…
Recent Articles and More
Before You Add Peptides to Your Practice
Peptide therapy has moved from elite biohacker circles into mainstream wellness offerings, and the marketing pitches arriving in your inbox suggest the…
HIPAA Update – Q1 2026
The first quarter of 2026 has brought a wave of regulatory activity, enforcement actions, and emerging compliance challenges under HIPAA. From a…
No, You Can’t Just Not Take Medicare: What Every Chiropractor Needs to Know
A growing number of chiropractors are moving away from insurance panels in favor of cash-pay practice models built around direct-pay patient relationships.…
Texas’s New IV Therapy Law: What Patients, Clinics, and Clinicians Need to Know
After a highly publicized death linked to an IV infusion at a Texas spa in 2023, state lawmakers moved to bring clearer…
